Rumble Stock Report: Price Plummets by 12.6%by Terry Bingman 29.03.2024Uncover the intriguing market dynamics of Rumble's financial performance. Dive into the full report for a comprehensive analysis. #NASDAQ #TechStocks
FBIO Stock Soars: Fortress Biotech Beats Q4 Earningsby Mark Eisenberg 29.03.2024Fortress Biotech's Q3 earnings per share of -53 cents exceeded the analyst estimate of -$1.97 while revenue of $19.95 million ...
BNR Stock Earnings: Burning Rock Biotech Q4 2023 Resultsby Mark Eisenberg 29.03.2024Burning Rock Biotech reported an earnings per share of -22 cents and revenue of $17.05 million. For concerns, contact [email protected].
Atlassian Co-CEO Sells $1.6M in Company Stockby Lilu Anderson 29.03.2024Multiple transactions of Atlassian shares were made through a trust at prices ranging from $192.61 to $195.06. Analysts expect net ...
JD Sports Reports Surge in Q4 Sales and Profit, Meeting Market Expectationsby Mark Eisenberg 29.03.2024JD Sports' recent trading update has been met with positive market reactions. However, forecasts for FY2025 were slightly lower than ...
Nuveen Real Asset Income and Growth Fund: Stock Price Slips By 0.7531%by Mark Eisenberg 29.03.2024Discover the latest on Nuveen Real Asset Income and Growth Fund's minor setback in stock price. Unlock full insights in ...
Warner Music Group Corp: Financial Report Reveals Market Trendsby Mark Eisenberg 29.03.2024Discover the financial stability and growth potential of Warner Music Group Corp (NASDAQ: WMG) in this insightful article. Uncover key ...
Apple sues ex-iOS engineer for leaking Vision Pro detailsby Lilu Anderson 29.03.2024Mr. Aude, an iOS engineer at Apple, faced termination after reading undisclosed features of an unannounced Apple product over the ...
CrowdStrike Stock: Ready for Another Surge?by Lilu Anderson 29.03.2024CrowdStrike stock emerges as the clear leader in the cybersecurity group, remaining resilient amidst market volatility with an 11% dip ...
Fortress Biotech Q4 Earnings Report: Analysts Predicted Lossby Mark Eisenberg 29.03.2024Fortress Biotech Inc's shares dropped 27.9% this quarter, exceeding analysts' predicted loss of $1.97 per share.